Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
D. Zou (Gothenburg, Sweden), Y. Celik (Istanbul, Turkey), T. Lindberg (Stockholm, Sweden), E. Thunström (Gothenburg, Sweden), Y. Peker (Istanbul, Turkey). Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial. 4740

Member's Comments

No comment yet.

Related content which might interest you: CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Rationale and design of the randomised intervention with CPAP in coronary artery disease and obstructive sleep apnoea – RICCADSA trial Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial Source: Eur Respir J 2016; 48: 142-150 Year: 2016 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Randomized placebo-controlled trial: effects of continuous positive airway pressure in patients with hypertension ²non dipper² without treatment and obstructive sleep apnea Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018 Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020 The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Treatment of central and obstructive sleep apnea in stable heart failure patients with auto-servo ventilation reduces sleep fragmentation – A randomized controlled trial Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults Year: 2011 Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Acetazolamide improves cardiac dysrhythmias in patients with obstructive sleep apnea at altitude. A randomized controlled trial Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012